“Additionally, the authors were unable to identify” co-author: Another retraction for Lemus

env microWe’ve been following the case of Jesús A. Lemus, the Spanish veterinary researcher with five retractions and two expressions of concern under his belt so far for suspected data fabrication and including a fake author on his papers.

Yes, a fake author. When this story first broke, El Pais called Javier Grande a ” ghost with a good academic background with at least six scientific publications in international journals.”

Grande’s — and Lemus’s — publication count declined by one more yesterday, as Environmental Microbiology retracted a 2007 paper: Continue reading “Additionally, the authors were unable to identify” co-author: Another retraction for Lemus

A new record: A retraction, 27 years later

jsbmbIn October, we noted the apparent record holder for longest time between publication and retraction: 25 years, for “Retention of the 4-pro-R hydrogen atom of mevalonate at C-2,2′ of bacterioruberin in Halobacterium halobium,” published in the Biochemical Journal in 1980 and retracted in 2005. (Although an author requested that another 52-year-old paper be retracted, it remains untouched in the literature.)

That record has now been broken. Congratulations to the Journal of Steroid Biochemistry and Molecular Biology and the authors of a December 1985 paper, “Increasing the response rate to cytotoxic chemotherapy by endocrine means.” Here’s the notice, which appears in the January 2013 issue of the journal, making 27 years — and a month, if you’re counting: Continue reading A new record: A retraction, 27 years later

“This publication should be ignored”: Authorship issues, flawed data fell neuro-oncology paper

Neon 2009 regular volume.inddThe Journal of Neuro-Oncology wants you to ignore the following paper: “A single chain (scFv425):sTRAIL fusion protein with specificity for the EGF receptor is effective in vitro but not in an in vivo brain tumor animal model.”

The 2007 article, from a group in The Netherlands, suffered from two fatal problems. According to the retraction notice: Continue reading “This publication should be ignored”: Authorship issues, flawed data fell neuro-oncology paper

Which came first? Plagiarism flap forces retraction of chicken nugget paper

food chem coverIt never pays to take a closer look at the inside of a chicken nugget.

The journal Food Chemistry has retracted a 2010 article by Iranian researchers who claimed to have used spectroscopy to examine the inner workings of breaded-fried chicken nuggets. Trouble was, someone else had already done the work.

Issues with the paper first surfaced in March, in the form of a correction that should have given the editors serious indigestion: Continue reading Which came first? Plagiarism flap forces retraction of chicken nugget paper

Retraction three for Dirk Smeesters

smeestersAmid criticisms this week that his former university didn’t do all it should have to investigate his work, another paper by Dirk Smeesters has been retracted.

Here’s the notice for “The effect of color (red versus blue) on assimilation versus contrast in prime-to-behavior effects,” which appeared in The Journal of Experimental Social Psychology: Continue reading Retraction three for Dirk Smeesters

Poignancy in physics: Retraction for “fatal error” that couldn’t be patched

prl-bannerIn August of last year, Mladen Pavičić, chair of physics at the University of Zagreb’s Faculty of Civil Engineering, published a paper in Physical Review Letters on quantum teleportation, “Near-Deterministic Discrimination of All Bell States with Linear Optics.”

Just six days later, after hearing from a physicist in China, Pavičić — who is also affiliated with Harvard’s physics department — submitted a correction, which ran on the journal’s site in November. The correction begins: Continue reading Poignancy in physics: Retraction for “fatal error” that couldn’t be patched

Heart retracts stent-ReoPro paper over data dispute with authors (save one)

We’re a few months late on this one, but Heart, a BMJ title, issued a fascinating retraction notice in August about a meta-analysis on percutaneous coronary intervention (that’s stenting to you and me) after suffering a heart attack, and the drug abciximab, which is used to prevent clotting and additional near-term heart attacks. Abciximab is sold as ReoPro by Eli Lilly.

The article, “Clinical impact of intracoronary abciximab in patients undergoing primary percutaneous coronary intervention: an individual patient-data pooled analysis of randomised studies,” was published last May. But according to the retraction notice, the authors had neglected to include fresh data, already in the literature before their paper went live, that contradicted their overall findings.

Here’s the notice: Continue reading Heart retracts stent-ReoPro paper over data dispute with authors (save one)

Going Dutch: Stapel inquiry eyes credulous colleagues, institution, prompts national soul search

Dutch investigators have released their final report into the case of Diederik Stapel, the social scientist and erstwhile faculty member at Tilburg University who fabricated data in 55 articles and book chapters. So far, 31 of Stapel’s published papers have been retracted — three others have expressions of concern — although more might follow.

In addition, 10 dissertations by students Stapel supervised were found to contain fraudulent data, although those students were cleared of any wrongdoing in the inquiry.

The report — and we’re going by rough translations here — found that Stapel’s colleagues and administrators seemed to accept his results at face value. Meanwhile, his high profile at Tilburg insulated him against initial rumblings about problems with his data. As the Dutch paper NRC Handelsblad reported: Continue reading Going Dutch: Stapel inquiry eyes credulous colleagues, institution, prompts national soul search

Odd: Retractions 18 and 19 for Dipak Das, and a new paper in the same journal, as if nothing were amiss

Dipak Das, the resveratrol researcher found guilty of more than 100 counts of misconduct by the University of Connecticut, has two more retractions for his resume. But that’s not the most interesting part of this post, so keep reading after the notices.

Both retractions appeared in the October 2012 issue of the Journal of Cellular and Molecular Medicine. Here’s the first notice: Continue reading Odd: Retractions 18 and 19 for Dipak Das, and a new paper in the same journal, as if nothing were amiss

Neuroscience paper retracted after HHMI investigation finds scientist copied images without permission

The Howard Hughes Medical Institute (HHMI) asked a journal to retract a paper once it became clear that some of the images in it were actually from a different HHMI lab.

Here’s the notice, from the Journal of Comparative Neurology: Continue reading Neuroscience paper retracted after HHMI investigation finds scientist copied images without permission